Synthesis and evaluation of 4-triazolylflavans as new aromatase inhibitors
Tipo de material:
TextoSeries ; Bioorganic & Medicinal Chemistry Letters, 14(20), p.5215-5218, 2004Trabajos contenidos: - Yahiaoui, S
- Pouget, C
- Fagnere, C
- Champavier, Y
- Habriouxa, G
- Chulia, A.J
| Item type | Current library | Collection | Call number | Status | Date due | Barcode | |
|---|---|---|---|---|---|---|---|
Documentos solicitados
|
CICY Documento préstamo interbibliotecario | Ref1 | B-7898 (Browse shelf(Opens below)) | Available |
Browsing CICY shelves, Shelving location: Documento préstamo interbibliotecario, Collection: Ref1 Close shelf browser (Hides shelf browser)
Aromatase is a target of pharmacological interest for the treatment of estrogen-dependent cancers. Azole derivatives such as letrozole or anastrozole have been developed for aromatase inhibition and are used for the treatment of breast tumors. In this paper, four 4-triazolylflavans were synthesized and were found to exhibit moderate to high inhibitory activity against aromatase.
There are no comments on this title.
Log in to your account to post a comment.
